Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Br J Anaesth ; 108(5): 830-7, 2012 May.
Article in English | MEDLINE | ID: mdl-22362670

ABSTRACT

BACKGROUND: A significantly increased risk of acute kidney injury (AKI) with the prophylactic use of aprotinin has been reported in adults undergoing cardiac surgery, but not in children. Blood product transfusions have also been shown to carry an independent risk of AKI. The present study assessed associations between AKI, aprotinin, and transfusions in neonates and infants undergoing cardiac surgery. METHODS: All neonates and infants undergoing surgery with cardiopulmonary bypass over a 42 month period, before and after the withdrawal of aprotinin, were included retrospectively. AKI was assessed by the Acute-Kidney-Injury-Network classifications. A propensity score was used to balance treated and untreated groups. RESULTS: Three hundred and ninety patients received aprotinin and 568 patients did not. Inverse probability of treatment weighting resulted in good balance between groups for baseline and surgical characteristics. Controls underwent surgery with smaller bypass circuits and fewer transfusions. After adjustment for the use of miniaturized circuits and for the year of surgery, no significant association between the incidence of AKI, dialysis, and aprotinin was noted. Red blood cell transfusions were associated with an increased risk of AKI and dialysis: odds ratios (ORs) 1.64 (1.12-2.41) and 2.07 (1.13-3.73), respectively; as were fresh frozen plasma transfusions, ORs 2.28 (1.68-3.09) and 3.11 (1.95-4.97), respectively. Platelet transfusions were associated with an increased risk of dialysis: OR 2.20 (1.21-4.01). CONCLUSIONS: Blood product transfusions, but not the prophylactic use of aprotinin, are significantly associated with AKI after cardiac surgery in neonates and infants.


Subject(s)
Acute Kidney Injury/etiology , Aprotinin/adverse effects , Blood Component Transfusion/adverse effects , Heart Defects, Congenital/surgery , Hemostatics/adverse effects , Acute Kidney Injury/chemically induced , Acute Kidney Injury/therapy , Aprotinin/therapeutic use , Blood Component Transfusion/methods , Blood Loss, Surgical/prevention & control , Cardiopulmonary Bypass , Drug Evaluation/methods , Hemostatics/therapeutic use , Humans , Infant , Infant, Newborn , Perioperative Care/methods , Postoperative Complications , Renal Dialysis , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL